Consequences of nucleic acid amplification testing for blood transfusion centres.
Reesink HW, Engelfriet CP, Vrielink H, Krusius T, Lankinen M, Flanagan P, Barbara J, Gill P, Dodd RY, Busch MP, Prati D, Mozzi F, Sirchia G, Diekamp U, Epstein JS, Tabor E, Martin-Vega C, Hernândez JM.
Reesink HW, et al. Among authors: vrielink h.
Vox Sang. 1998;74(4):263-70.
Vox Sang. 1998.
PMID: 9691411
No abstract available.